Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 124
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Impact of Soylent Consumption on Human Microbiome Composition

As students carry out their busy lifestyles, many are turning to inexpensive and convenient drink based...

Ebola video voice-over recording in 10 African local languages

Ebola virus is spreading rapidly in West Africa. We are sharing a 3D animation explaining the symptoms of...

A Leap Forward to Cure a Neglected Disease

The World Health Organization estimates that as many as 11 million people worldwide are infected with the...

Backer Badge Funded